← Back to headlines
Big Pharma Invests in Psychedelic-Based Medicines
Major pharmaceutical companies are investing in the development of drugs based on hallucinogenic substances, including toad venom and psychedelic mushrooms, with the Donald Trump administration reportedly giving the green light for these new medications.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
